Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel B Shin

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Journal of the American Academy of Dermatology|August 1, 2012
Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasisHowa Yeung, Joy Wan, Abby S Van Voorhees, et al.
Journal of the American Academy of Dermatology|June 5, 2019
Patient-reported outcomes of adalimumab, phototherapy, and placebo in the Vascular Inflammation in Psoriasis Trial: A randomized controlled studyMegan H Noe, Marilyn T Wan, Daniel B Shin, et al.
Journal of Psoriasis and Psoriatic Arthritis|May 21, 2026
Addressing Cardiovascular Risk in People With Psoriatic Disease Using a Care Coordinator Model: A Qualitative Analysis of a Pilot StudyJennifer B Mason, Christina Johnson, Nkiru Ogbuefi, et al.
Archives of Dermatology|April 18, 2012
Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice settingJoel M Gelfand, Joy Wan, Kristina Callis Duffin, et al.
Journal of the American Academy of Dermatology|September 28, 2014
Comparative effectiveness of less commonly used systemic monotherapies and common combination therapies for moderate to severe psoriasis in the clinical settingJunko Takeshita, Shuwei Wang, Daniel B Shin, et al.
The Journal of Investigative Dermatology|January 6, 2024
A Care Coordination Model to Prevent Cardiovascular Events in Patients with Psoriatic Disease: A Multicenter Pilot StudyWilliam B Song, Michael S Garshick, John S Barbieri, et al.
JAMA Dermatology|September 21, 2022
Association of Apremilast With Vascular Inflammation and Cardiometabolic Function in Patients With Psoriasis: The VIP-A Phase 4, Open-label, Nonrandomized Clinical TrialJoel M Gelfand, Daniel B Shin, April W Armstrong, et al.
The Journal of Investigative Dermatology|February 24, 2020
A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S)Joel M Gelfand, Daniel B Shin, Kristina Callis Duffin, et al.
Circulation. Cardiovascular Imaging|May 20, 2018
Effect of 2 Psoriasis Treatments on Vascular Inflammation and Novel Inflammatory Cardiovascular Biomarkers: A Randomized Placebo-Controlled TrialNehal N Mehta, Daniel B Shin, Aditya A Joshi, et al.
JAMA Dermatology|September 25, 2024
Home- vs Office-Based Narrowband UV-B Phototherapy for Patients With Psoriasis: The LITE Randomized Clinical TrialJoel M Gelfand, April W Armstrong, Henry W Lim, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Journal of the American Academy of Dermatology|August 1, 2012
Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasisHowa Yeung, Joy Wan, Abby S Van Voorhees, et al.
Journal of the American Academy of Dermatology|June 5, 2019
Patient-reported outcomes of adalimumab, phototherapy, and placebo in the Vascular Inflammation in Psoriasis Trial: A randomized controlled studyMegan H Noe, Marilyn T Wan, Daniel B Shin, et al.
Journal of Psoriasis and Psoriatic Arthritis|May 21, 2026
Addressing Cardiovascular Risk in People With Psoriatic Disease Using a Care Coordinator Model: A Qualitative Analysis of a Pilot StudyJennifer B Mason, Christina Johnson, Nkiru Ogbuefi, et al.
Archives of Dermatology|April 18, 2012
Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice settingJoel M Gelfand, Joy Wan, Kristina Callis Duffin, et al.
Journal of the American Academy of Dermatology|September 28, 2014
Comparative effectiveness of less commonly used systemic monotherapies and common combination therapies for moderate to severe psoriasis in the clinical settingJunko Takeshita, Shuwei Wang, Daniel B Shin, et al.
The Journal of Investigative Dermatology|January 6, 2024
A Care Coordination Model to Prevent Cardiovascular Events in Patients with Psoriatic Disease: A Multicenter Pilot StudyWilliam B Song, Michael S Garshick, John S Barbieri, et al.
JAMA Dermatology|September 21, 2022
Association of Apremilast With Vascular Inflammation and Cardiometabolic Function in Patients With Psoriasis: The VIP-A Phase 4, Open-label, Nonrandomized Clinical TrialJoel M Gelfand, Daniel B Shin, April W Armstrong, et al.
The Journal of Investigative Dermatology|February 24, 2020
A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S)Joel M Gelfand, Daniel B Shin, Kristina Callis Duffin, et al.
Circulation. Cardiovascular Imaging|May 20, 2018
Effect of 2 Psoriasis Treatments on Vascular Inflammation and Novel Inflammatory Cardiovascular Biomarkers: A Randomized Placebo-Controlled TrialNehal N Mehta, Daniel B Shin, Aditya A Joshi, et al.
JAMA Dermatology|September 25, 2024
Home- vs Office-Based Narrowband UV-B Phototherapy for Patients With Psoriasis: The LITE Randomized Clinical TrialJoel M Gelfand, April W Armstrong, Henry W Lim, et al.
Pageof 10